Seiyu admits faking credentials for workers

Seiyu admits faking credentials for workers

TOKYO, Japan - Takeshi Kamigochi (L), executive officer and senior vice president of Seiyu GK, and Ryo Kanayama, executive officer and senior vice president of the company, bow during a press conference in Tokyo on Nov. 6, 2012, in which they apologized for falsifying the work experience of its workers so that they could take qualification examinations as pharmaceutical sales clerks.

  • Product Code
  • ILEA001176514
  • Registered date
  • 2012/11/06 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2012 Kyodo News
  • Media size
  • 2520 × 2010 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 492.95(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Avigan could be formally approved as Ebola drug early 2015

    Avigan could be formally approved as Ebola drug early 2015

    TOKYO, Japan - Shigetaka Komori, chief executive officer of Fujifilm Holdings Corp., attends a press conference in Tokyo, Japan, on Nov. 11, 2014, announcing that the company expects its Avigan anti-influenza drug to be formally approved early next year for treating people infected with the Ebola virus.
      Research to start on blood tests to detect 13 cancer types

      Research to start on blood tests to detect 13 cancer types

      TOKYO, Japan - Researchers announce the commencement of a project to develop ways of detecting 13 types of cancer from a single blood sample at a press conference in Tokyo on Aug. 18, 2014. Making the announcement were Kenji Kurata (L), president of the New Energy and Industrial Technology Development Organization, Tomomitsu Hotta (C), president of the National Cancer Center, and Tetsu Yonehara, head of Toray Industries Inc.'s New Frontiers Research Laboratories.
        Novartis management replaced

        Novartis management replaced

        TOKYO, Japan - David Epstein (L), president of Swiss pharmaceutical giant Novartis speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors. At right is new Novartis Pharma K.K. President Dirk Kosche.
          Novartis management replaced

          Novartis management replaced

          TOKYO, Japan - David Epstein, president of Swiss pharmaceutical giant Novartis holds a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
            Novartis management replaced

            Novartis management replaced

            TOKYO, Japan - Dirk Kosche, new president of Novartis Pharma K.K., speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of Swiss pharmaceutical giant Novartis announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
              Takeda chief apologizes over data misuse in drug ad

              Takeda chief apologizes over data misuse in drug ad

              TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.
                Takeda chief apologizes over data misuse in drug ad

                Takeda chief apologizes over data misuse in drug ad

                TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.
                  Online sales of over-the-counter drugs

                  Online sales of over-the-counter drugs

                  TOKYO, Japan - Hiroshi Mikitani, president of online shopping mall Rakuten Inc., speaks to reporters in Tokyo on Nov. 6, 2013, following the government's announcement that online sales of drugs moving from prescription to over-the-counter status will be banned for three years from the point of such movement in principle under new rules that could take effect next spring. Mikitani slammed the government-planned restrictions on online sales of over-the-counter drugs as "unconstitutional" and suggested he will take the case to court.
                    Online sales of over-the-counter drugs

                    Online sales of over-the-counter drugs

                    TOKYO, Japan - Health, Labor and Welfare Minister Norihisa Tamura holds a press conference at the ministry in Tokyo on Nov. 6, 2013. The government said the same day that online sales of drugs moving from prescription to over-the-counter status will be banned for three years from the point of such movement in principle under new rules that could take effect next spring.
                      Japan Tobacco to undertake drastic restructuring

                      Japan Tobacco to undertake drastic restructuring

                      TOKYO, Japan - Japan Tobacco Co. Vice President Akira Saeki speaks at a news conference in Tokyo on Oct. 30, 2013, as the company said it will close four of its nine cigarette manufacturing-related factories in Japan and a vending machine production base, most of them in March 2015, and cut 1,600 jobs, or about 20 percent of the employees in its tobacco business, due to falling sales.